Avenir Corporation’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $271K | Hold |
1,462
| – | – | 0.03% | 65 |
|
2025
Q1 | $306K | Hold |
1,462
| – | – | 0.03% | 57 |
|
2024
Q4 | $260K | Hold |
1,462
| – | – | 0.03% | 60 |
|
2024
Q3 | $289K | Hold |
1,462
| – | – | 0.03% | 58 |
|
2024
Q2 | $251K | Hold |
1,462
| – | – | 0.02% | 62 |
|
2024
Q1 | $266K | Hold |
1,462
| – | – | 0.02% | 61 |
|
2023
Q4 | $227K | Hold |
1,462
| – | – | 0.02% | 60 |
|
2023
Q3 | $218K | Buy |
+1,462
| New | +$218K | 0.02% | 57 |
|
2023
Q2 | – | Sell |
-1,462
| Closed | -$233K | – | 61 |
|
2023
Q1 | $233K | Hold |
1,462
| – | – | 0.02% | 59 |
|
2022
Q4 | $236K | Buy |
+1,462
| New | +$236K | 0.02% | 58 |
|
2022
Q3 | – | Sell |
-1,462
| Closed | -$224K | – | 61 |
|
2022
Q2 | $224K | Hold |
1,462
| – | – | 0.02% | 58 |
|
2022
Q1 | $237K | Buy |
+1,462
| New | +$237K | 0.02% | 61 |
|